Market Overview
Overview
- The elderly care products market reached USD 48.8 billion in 2025 and will reach USD 83.3 billion by 2035, expanding at a 5.4% CAGR.
- The market encompasses durable and consumable products designed for, marketed to, or predominantly used by adults aged 60 years and older.
- It includes mobility and rehabilitation equipment, bathroom safety products, comfort care products, medical devices, incontinence products, nutritional supplements, and daily living aids.
- It excludes healthcare services, facility fees, home-care labor, prescription drugs, hospital capital equipment, senior housing, and standalone care software.
- Market Leader: Medline Industries LP led with over 12% market share in 2025.
- Leading Players: Top 5 players in this market include Medline Industries LP, Abbott, Essity, Koninklijke Philips NV, Sonova, which collectively held a market share of 40% in 2025.
- Demand rests on a durable demographic base.
- The global population aged 65 and older reached 829 million in 2024 and is expected to reach 1.6 billion by 2050.
- United Nations, “World Population Prospects 2024,”, un.org Chronic-condition management adds recurring demand for blood pressure monitors, respiratory equipment, hearing aids, nutritional products, and incontinence care.
- In the United States, 85% of adults aged 65 and older manage at least one chronic condition, while more than 60% manage two or more.
- Centers for Disease Control and Prevention, “Chronic Disease and Older Adults,”, cdc.gov
- Three developments shape the market.
Market Dynamics
Overview
- Market Leader: Medline Industries LP led with over 12% market share in 2025.
- Leading Players: Top 5 players in this market include Medline Industries LP, Abbott, Essity, Koninklijke Philips NV, Sonova, which collectively held a market share of 40% in 2025.
Segmentation Analysis
By Product Type
- Medical Devices held 20.1% of market revenue in 2024 and will expand at a 5.6% CAGR through 2035.
- Hearing aids, CPAP systems, blood pressure monitors, and remote-capable therapy equipment link this segment to persistent chronic-disease management.
- The FDA’s over-the-counter hearing aid rule improves access at the entry end of hearing care.
- Nutritional Supplements held 18.8% and will also grow at 5.6%, supported by protein supplementation, diabetes-specific nutrition, and online replenishment.
- Incontinence Products accounted for 16.5% of 2024 revenue, and Mobility Products represented 13.9%.
- Both remain volume anchors, especially in long-term care and home-based use.
- Their share will grow more slowly than that of medical and nutrition categories because simpler products face greater price competition.
- Comfort Care, Bathroom Safety, and Daily Living Aids & Others provide a broad home-independence layer, ranging from pressure relief and lift chairs to grab bars, pill organizers, and adaptive utensils.
By Care Type
- Home Care & Independent Living is the largest care-type segment because it serves the dominant living arrangement for older adults.
- Chronic Disease Management supports the highest-value recurring demand across monitoring, respiratory therapy, diabetes care, and nutrition.
- Post-Acute Rehabilitation requires higher-specification wheelchairs, positioning systems, and hospital-style beds.
- Palliative & End-of-Life Care concentrates demand for incontinence, comfort, and skin-care products, while Preventive Health increasingly uses home blood pressure monitoring and supplements.
By End Use
- Home-Based Care represented approximately 40% of 2024 revenue and will grow at an estimated 5.9% CAGR.
- Its scale reflects both household need and the migration of discharge care into residential settings.
- Nursing Homes & Skilled Nursing Facilities remain the institutional volume anchor for continence, wound, and pressure-management products.
- Hospitals & Clinics maintain demand for prescribed equipment and discharge planning.
- Assisted Living & Continuing Care Retirement Communities are expanding as an intermediate care setting, while Adult Day Care & Rehabilitation Centers remain the smallest end-use category.
By Distribution Channel
- Offline channels held 72% of 2024 revenue.
- Pharmacies, specialty durable medical equipment dealers, and institutional procurement remain indispensable for products needing assessment, fitting, insurance billing, maintenance, or clinician direction.
- Medline’s 69-distribution-center network and next-day service to approximately 95% of U.S. healthcare customers show why institutional logistics remain strategically valuable.
- Medline Industries LP, medline.com
- Online channels accounted for 28% of 2024 revenue and will reach 43% by 2035.
- Nutritional supplements, incontinence products, and daily living aids are most suited to e-commerce because they are replenishable and require limited clinical intervention.
- Complex mobility equipment will remain primarily offline.
- The second-order effect is a widening gap between firms that merely list products online and firms that can integrate fulfillment, clinical education, and recurring engagement.
North America
- North America generated USD 15.4 billion in 2024 and will reach USD 25.8 billion by 2035 at a 4.8% CAGR.
- Medicare and Medicaid durable medical equipment coverage support product access, while high per-capita health spending supports premium devices.
- Medicare, “Durable Medical Equipment Coverage,”, medicare.gov Europe will increase from USD 11.2 billion to USD 19.6 billion at a 5.2% CAGR.
- Germany’s reimbursement structure and mature institutional procurement underpin demand, while the UK, France, Italy, and Spain supply varied public and private purchasing channels.
Asia Pacific
- Asia Pacific will expand from USD 10.7 billion in 2024 to USD 22.6 billion in 2035 at a 6.9% CAGR.
- China’s Silver Economy agenda, Japan’s Long-Term Care Insurance system, and India’s expanding elderly middle class create different routes to growth.
- Japan Ministry of Health, Labour and Welfare, “Long-Term Care Insurance System,”, mhlw.go.jp Latin America will grow from USD 2.3 billion to USD 4.7 billion at a 6.5% CAGR, led by Brazil and Mexico, although affordability constrains premium-device penetration.
- Middle East & Africa will rise from USD 1.9 billion to USD 4.1 billion at a 7.4% CAGR as Saudi Arabia and the UAE expand healthcare infrastructure.
Brevintel Analyst View
- Asia Pacific will become the principal source of share gain through 2035, while North America will remain the highest-value mature market.
- The difference is strategic rather than demographic alone.
- North America rewards reimbursement navigation, direct fulfillment, and clinical support; Asia Pacific rewards localized product design, price architecture, and diversified distribution.
- Global suppliers that treat the region as a single market will underperform local specialists that match product complexity to country purchasing power.
Competitive Landscape
Overview
- The market is moderately concentrated. Medline Industries LP led with an estimated 12% global share in 2024, and Medline, Abbott, Essity, Koninklijke Philips NV, and Sonova collectively accounted for approximately 40%. The remaining revenue is distributed across category specialists, regional manufacturers, private-label suppliers, and local distributors. Concentration differs sharply by product category: nutrition, incontinence, hearing care, respiratory therapy, and…
- Medline’s position stems from institutional distribution breadth across long-term care, home health, hospice, and acute care. Abbott combines the Ensure and Glucerna franchise with diabetes-monitoring exposure. Essity’s TENA platform provides a strong institutional and retail incontinence position. Philips competes across connected care, respiratory products, personal health, and Lifeline personal emergency response. Sonova’s hearing-care position rests on Phonak,…
- The score indicates meaningful entry barriers in regulated and clinically specified categories, but not market-wide pricing power. Further consolidation is most likely where distribution density, reimbursement capability, and connected-care investment can be combined. Category specialists retain defensible positions where fitting, local service, or clinical credibility matter more than broad product breadth.
- Brevintel Analyst View
- The market does not favor a single universal winner. Distribution-led firms will continue to lead high-volume institutional categories, while medical-device and hearing-care specialists will defend premium segments through clinical performance and service networks. The more consequential consolidation opportunity lies at the intersection of products and care coordination. Companies that can attach software, replenishment, or home-health workflow support to a physical…
- Elderly Care Products Market Companies (15 companies)
- Abbott - Abbott competes through Ensure, Glucerna, other adult nutritional products, and FreeStyle Libre diabetes monitoring. FY2024 revenue was USD 41,950 million; Nutritional Products contributed USD 8,413 million. Abbott Laboratories, “2024 Annual Report,”, sec.gov Its differentiation is the combination of clinically recognized nutrition brands and chronic-disease management.
- Baxter International - Baxter’s elderly-care relevance is concentrated in smart beds, connected patient systems, parenteral nutrition, and institutional therapies. FY2024 continuing-operations revenue was USD 10,636 million following the Vantive Kidney Care divestiture. Comparisons with prior all-in revenue require caution because the elderly-relevant portfolio is primarily clinical.
- Bruno Independent Living Aids - Bruno focuses on stairlifts, platform lifts, and vehicle accessibility products for independent living. Its active GSA Schedule contract for patient mobility devices runs from 2024 to 2029. The company’s differentiation is installation-led mobility access rather than broad medical supply.
- Drive DeVilbiss Healthcare - Drive DeVilbiss supplies mobility aids, bathroom safety equipment, respiratory products, beds, and home-care products. It received FDA clearance for a home-use portable oxygen concentrator in February 2024. Kingswood Capital acquired the company in October 2025; the ownership change occurred after the base year, and operations continued under the established brand.
- Essity - Essity’s TENA franchise gives it broad exposure to institutional and retail incontinence care. FY2024 net sales were SEK 145,500 million, replacing the prior FY2023 reference. The May 2024 UK launch of the TENA SmartCare Change Indicator extends the portfolio toward connected workflow support.
- Golden Technologies - Golden Technologies is a private mobility specialist in lift chairs, scooters, power wheelchairs, and adjustable beds. The working revenue estimate is USD 100–150 million because audited disclosure is unavailable. Its USD 113 million Veterans Affairs mobility scooter contract for 2024–2029 reinforces its government procurement position.